Buena Park, CA, United States of America

Hyung-Gyoo Kang


Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2018-2022

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Hyung-Gyoo Kang in Cancer Treatment

Introduction

Hyung-Gyoo Kang is an accomplished inventor based in Buena Park, California. He has made significant contributions to the field of drug delivery systems, particularly in cancer treatment. With a total of three patents to his name, Kang's work focuses on innovative solutions that enhance the efficacy of therapeutic agents.

Latest Patents

One of Kang's notable inventions is the development of targeted polymerized nanoparticles for cancer treatment. This invention relates to a novel drug delivery vehicle that utilizes a hybrid polymerized liposomal nanoparticle. The nanoparticle comprises both polymerizable lipids and non-polymerizable lipids, allowing for the loading of therapeutic agents. Additionally, targeting agents can be conjugated to the surface of the polymerized liposomal nanoparticle. This invention also includes methods, compositions, and kits designed to utilize the hybrid polymerized liposomal nanoparticle for treating various cancer conditions.

Career Highlights

Throughout his career, Hyung-Gyoo Kang has worked with reputable organizations, including Children's Hospital Los Angeles and Nanovalent Pharmaceuticals, Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Kang has had the opportunity to work alongside notable colleagues such as Jon O Nagy and Tim Triche. These collaborations have further enriched his research and development efforts in the realm of cancer treatment.

Conclusion

Hyung-Gyoo Kang's innovative work in developing targeted polymerized nanoparticles represents a significant advancement in cancer treatment. His contributions to drug delivery systems highlight the potential for improved therapeutic outcomes in patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…